These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3832781)

  • 1. Methods for the evaluation of solid state stability and compatibility between drug and excipient.
    Ahlneck C; Lundgren P
    Acta Pharm Suec; 1985; 22(6):305-14. PubMed ID: 3832781
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-excipient compatibility screening--role of thermoanalytical and spectroscopic techniques.
    Chadha R; Bhandari S
    J Pharm Biomed Anal; 2014 Jan; 87():82-97. PubMed ID: 23845418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and utilization of the drug-excipient chemical compatibility automated system.
    Thomas VH; Naath M
    Int J Pharm; 2008 Jul; 359(1-2):150-7. PubMed ID: 18486368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding drug-excipient compatibility: oxidation of compound A in a solid dosage form.
    Wu Y; Dali M; Gupta A; Raghavan K
    Pharm Dev Technol; 2009; 14(5):556-64. PubMed ID: 19743950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factorial designs in pharmaceutical preformulation studies. II. Studies on drug stability and compatibility in the solid state.
    Ahlneck C; Waltersson JO
    Acta Pharm Suec; 1986; 23(3):139-50. PubMed ID: 3766159
    [No Abstract]   [Full Text] [Related]  

  • 6. Compatibility studies of promethazine hydrochloride with tablet excipients by means of thermal and non-thermal methods.
    Thumma S; Repka MA
    Pharmazie; 2009 Mar; 64(3):183-9. PubMed ID: 19348341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compatibility of chewing gum excipients with the amino acid L-cysteine and stability of the active substance in directly compressed chewing gum formulation.
    Kartal A; Björkqvist M; Lehto VP; Juppo AM; Marvola M; Sivén M
    J Pharm Pharmacol; 2008 Sep; 60(9):1131-8. PubMed ID: 18718115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid-state compatibility studies using a high-throughput and automated forced degradation system.
    Wakasawa T; Sano K; Hirakura Y; Toyo'oka T; Kitamura S
    Int J Pharm; 2008 May; 355(1-2):164-73. PubMed ID: 18215480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of mixture design in drug-excipient compatibility determinations: Thymol nanoparticles case study.
    Pires FQ; Angelo T; Silva JK; Sá-Barreto LC; Lima EM; Gelfuso GM; Gratieri T; Cunha-Filho MS
    J Pharm Biomed Anal; 2017 Apr; 137():196-203. PubMed ID: 28131059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new approach to accelerated drug-excipient compatibility testing.
    Sims JL; Carreira JA; Carrier DJ; Crabtree SR; Easton L; Hancock SA; Simcox CE
    Pharm Dev Technol; 2003; 8(2):119-26. PubMed ID: 12760562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PharmDE: A new expert system for drug-excipient compatibility evaluation.
    Wang N; Sun H; Dong J; Ouyang D
    Int J Pharm; 2021 Sep; 607():120962. PubMed ID: 34339812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential scanning calorimetry to investigate the compatibility of ciprofloxacin hydrochloride with excipients.
    Fathy M; Hassan MA; Mohamed FA
    Pharmazie; 2002 Dec; 57(12):825-8. PubMed ID: 12561245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability challenges in drug discovery.
    Di L; Kerns EH
    Chem Biodivers; 2009 Nov; 6(11):1875-86. PubMed ID: 19937822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of HPLC to assess the compatibility of bisoprolol fumarate with selected excipients in mixtures by isothermal stress testing.
    Marothu VK; Yerramothu P; Gorrepati M; Majeti S; Mamidala SK; Nellutla A
    Ann Pharm Fr; 2015 Nov; 73(6):442-51. PubMed ID: 26142745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards safer and efficient formulations: Machine learning approaches to predict drug-excipient compatibility.
    Hang NT; Long NT; Duy ND; Chien NN; Van Phuong N
    Int J Pharm; 2024 Mar; 653():123884. PubMed ID: 38341049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compatibility of sennoside A and B with pharmaceutical excipients.
    Verloop Q; Marais AF; de Villiers MM; Liebenberg W
    Pharmazie; 2004 Sep; 59(9):728-30. PubMed ID: 15497761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermal and non-thermal methods to evaluate compatibility of granisetron hydrochloride with tablet excipients.
    Late SG; Banga AK
    Pharmazie; 2008 Jun; 63(6):453-8. PubMed ID: 18604989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical excipient development: the need for preclinical guidance.
    Baldrick P
    Regul Toxicol Pharmacol; 2000 Oct; 32(2):210-8. PubMed ID: 11067777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a screening method to determine excipients which optimize the extent and stability of supersaturated drug solutions and application of this system to solid formulation design.
    Vandecruys R; Peeters J; Verreck G; Brewster ME
    Int J Pharm; 2007 Sep; 342(1-2):168-75. PubMed ID: 17573214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium sulphate dihydrate: an useful excipient for tablets containing labile actives.
    Eyjolfsson R
    Pharmazie; 2004 Sep; 59(9):725-6. PubMed ID: 15497759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.